<DOC>
	<DOCNO>NCT01678300</DOCNO>
	<brief_summary>The purpose protocol : 1 . To quantify prevalence adherence topical mesalamine patient UC 2 . To describe determinant medication adherence patient UC prescribe topical mesalamine</brief_summary>
	<brief_title>Qualitative Study Topical Mesalamine Adherence Patients With Ulcerative Colitis ( UC )</brief_title>
	<detailed_description>Patient adherence topical mesalamine low . Behavioral psycho-social barrier topical mesalamine adherence exist patient UC . These factor identify use qualitative test order develop design appropriate behavioral intervention reduce non-adherence . The investigator undertake observational study medication persistence 100 patient BIDMC clinic , `` Persistence Cohort '' . Persistence measure use 12-month pharmacy refill data . The investigator also employ qualitative research design discrete choice model two phase : Phase I - Initial Interviews 10 patient Phase II - Focus Groups ( 2 ) 5 patient .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>must ulcerative colitis diagnose doctor least 1 month prior study participation must prescribe topical mesalamine ( e.g . Rowasa enemas Canasa suppository ) doctor must receive care Beth Israel Deaconess Medical Center diagnosis ulcerative colitis prescription topical mesalamine receive care Beth Israel Deaconess Medical Center</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>